Literature DB >> 14423204

A critical analysis of the use of salicylazosulfapyridine in chronic ulcerative colitis.

C G MOERTEL, J A BARGEN.   

Abstract

Entities:  

Keywords:  COLITIS, ULCERATIVE/therapy; SULFONAMIDES/therapy

Mesh：

Substances：

Year:  1959        PMID： 14423204     DOI： 10.7326/0003-4819-51-5-879

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  18 in total

1.  CONTROLLED TRIAL OF SULPHASALAZINE IN THE TREATMENT OF ULCERATIVE COLITIS.

Authors:  A P DICK; M J GRAYSON; R G CARPENTER; A PETRIE
Journal:  Gut       Date:  1964-10       Impact factor: 23.059

2.  Comparison of corticosteroid and sulphasalazine therapy in ulcerative colitis.

Authors:  S C TRUELOVE; G WATKINSON; G DRAPER
Journal:  Br Med J       Date:  1962-12-29

3.  The medical treatment of ulcerative colitis.

Authors:  G WATKINSON
Journal:  Postgrad Med J       Date:  1962-12       Impact factor: 2.401

4.  An assessment of prednisone, salazopyrin, and topical hydrocortisone hemisuccinate used as out-patient treatment for ulcerative colitis.

Authors:  J E LENNARD-JONES; A J LONGMORE; A C NEWELL; C W WILSON; F A JONES
Journal:  Gut       Date:  1960-09       Impact factor: 23.059

5.  A comparative trial of salazopyrin, prednisone and hydrocortisone retention enemata in the out-patient treatment of left-sided colitis. Preliminary report.

Authors:  J E LENNARD-JONES; A J LONGMORE; F A JONES
Journal:  Proc R Soc Med       Date:  1960-08

6.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

7.  Leukocytapheresis therapy, performed with leukocyte removal filter, for inflammatory bowel disease.

Authors:  K Sawada; K Ohnishi; S Fukui; K Yamada; M Yamamura; K Amano; K Amano; M Wada; N Tanida; M Satomi
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

8.  Salicylazosulfapyridine in inflammatory bowel disease.

Authors:  K M Das; I Sternlieb
Journal:  Am J Dig Dis       Date:  1975-10

9.  The metabolism of salicylazosulphapyridine in ulcerative colitis: II The relationship between metabolites and the progress of the disease studied in outpatients.

Authors: 
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

10.  Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.

Authors:  H Schröder; D A Evans
Journal:  Gut       Date:  1972-04       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.